Rivernorth Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-44,868
| Closed | -$3.59K | – | 494 |
|
|
2023
Q4 | $3.59K | Hold |
44,868
| – | – | ﹤0.01% | 394 |
|
|
2023
Q3 | $2.34K | Hold |
44,868
| – | – | ﹤0.01% | 486 |
|
|
2023
Q2 | $4.04K | Hold |
44,868
| – | – | ﹤0.01% | 484 |
|
|
2023
Q1 | $2.69K | Buy |
44,868
+31,536
| +237% | +$1.89K | ﹤0.01% | 578 |
|
|
2022
Q4 | $667 | Hold |
13,332
| – | – | ﹤0.01% | 701 |
|
|
2022
Q3 | $1K | Hold |
13,332
| – | – | ﹤0.01% | 841 |
|
|
2022
Q2 | $2K | Hold |
13,332
| – | – | ﹤0.01% | 788 |
|
|
2022
Q1 | $4K | Hold |
13,332
| – | – | ﹤0.01% | 803 |
|
|
2021
Q4 | $7K | Hold |
13,332
| – | – | ﹤0.01% | 709 |
|
|
2021
Q3 | $7K | Buy |
+13,332
| New | +$7K | ﹤0.01% | 560 |
|